1.3400
-0.0400
(-2.90%)
At close: January 28 at 4:00:01 PM EST
1.4100
+0.07
+(5.22%)
After hours: 7:45:37 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
61,530.0000
91,283.0000
83,400.9350
99,533.8000
Total Liabilities Net Minority Interest
24,445.0000
25,601.0000
17,908.8630
20,622.3280
Total Equity Gross Minority Interest
37,085.0000
65,682.0000
65,492.0720
78,911.4720
Total Capitalization
41,287.0000
73,717.0000
65,492.0720
78,911.4720
Common Stock Equity
37,085.0000
65,682.0000
65,492.0720
78,911.4720
Capital Lease Obligations
6,530.0000
9,318.0000
10,052.8540
7,146.2140
Net Tangible Assets
37,085.0000
65,682.0000
65,492.0720
78,911.4720
Working Capital
34,373.0000
65,639.0000
55,680.4350
71,211.4380
Invested Capital
45,250.0000
75,680.0000
65,492.0720
78,911.4720
Tangible Book Value
37,085.0000
65,682.0000
65,492.0720
78,911.4720
Total Debt
14,695.0000
19,316.0000
10,052.8540
7,146.2140
Share Issued
47,215.1160
43,042.5480
32,202.4960
30,351.3660
Ordinary Shares Number
47,215.1160
43,042.5480
32,202.4960
30,351.3660
12/31/2020 - 1/2/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IZTC Invizyne Technologies, Inc.
14.42
+3.37%
ACTU Actuate Therapeutics, Inc. Common stock
9.29
-8.74%
APTO Aptose Biosciences Inc.
0.1918
-5.70%
GANX Gain Therapeutics, Inc.
2.0800
-2.80%
INAB IN8bio, Inc.
0.2738
+2.43%
ANTX AN2 Therapeutics, Inc.
1.2300
-2.38%
RNTX Rein Therapeutics Inc.
2.4900
+18.57%
ABOS Acumen Pharmaceuticals, Inc.
1.6000
-1.23%
THAR Tharimmune, Inc.
1.9750
-1.74%
LYEL Lyell Immunopharma, Inc.
0.6095
-2.73%